Moderator
Anne V. Maher, Parter, Kleinfeld, Kaplan & Becker LLP

Speakers
Richard Cleland, Esq., Assistant Director, Division of Advertising Practices,
Federal Trade Commission
Robert J. Moore, PhD, Supervisor, Regulations Implementations Team,
Division of Dietary Supplement Programs, Office of Nutrition, Labeling and Dietary Supplements, Food and Drug Administration
Bruce A. Silverglade, Director of Legal Affairs, Center for Science in the Public Interest

Program Description
Listen to the relevant regulators discuss product claims along the spectrum from immune system support, to enhancing immunity, to strengthening the immune system, to preventing colds and flu, to preventing H1N1 influenza. Such claims currently appear in a wide variety products and in diverse contexts. Dr. Robert Moore will talk about the FDA’s joint initiative with FTC against companies marketing fraudulent anti-H1N1 influenza products and about the agency’s approach to more general immune system and immunity claims. Richard Cleland will discuss FTC’s expanded enforcement activities involving unsubstantiated immunity and immune system boosting claims, including the FTC’s recent cases against chain retailers for claims on their store brands. The panel will also discuss their views regarding consumers’ interpretation of immunity related claims, and in particular how and if general immunity claims take on a different meaning and impact in the face of highly publicized flu pandemic. They will also provide practical tips for complying with FTC and FDA food and dietary supplement advertising and labeling requirements in an interactive, live, web-based program. The panelists’ prepared remarks, which will be simultaneously displayed via internet, will be followed by an ample open discussion and question and answer period to allow the audience to participate from the comfort of their offices. Don’t miss this lively discussion on a timely topic.

Who Should Attend?
Attendance at this webinar is ideal for those interested in learning more about both the FDA’s and FTC’s approaches to claims for products marketed to boost immunity and strengthen the immune system. Participants with a beginning or intermediate knowledge of the subject will gain insight from the program.

Handouts
Slides will be made available to registrants before the webinar.

Registration Fees
$295 Member
$495 Non-member
$295 Academics & Government

Special CD Price!
Purchase the CD set for just $75 with your registration. To receive the special price, CDs must be purchased at the time of registration. Offer limited to one CD set per registrant. In order to use this CD, your portable CD player or computer player must be able to support the MP3 format. Shipping & handling charges will apply.

Tax: CD orders shipped to Washington, DC and Maryland addresses will be
charged 6% sales tax.

Please contact Customer Service at (800) 956-6293 or (202) 371-1420,
or by e-mail at service@fdli.org, if you have any questions about your conference registration or CD order.

ANNE V. MAHER is a Partner in the law firm of Kleinfeld Kaplan & Becker LLP (KKB) in Washington, DC specializing in the needs of Food and Drug Administration (FDA)-regulated companies and related entities. She practices in the area of advertising and consumer protection regulation. She counsels clients on food, drug, dietary supplement, cosmetic and device promotional issues and requirements and represents clients in investigations and advertising challenges. She frequently speaks at industry and association meetings involving advertising law and policy. Before joining KKB, she was the Assistant Director for Advertising Practices Division in the Federal Trade Commission’s (FTC) Bureau of Consumer Protection. She supervised law enforcement investigations and industry outreach. Prior to her appointment as Assistant Director, she served in the Office of the Director, Bureau of Consumer Protection, and as Attorney Advisor to an FTC Commissioner and as a staff attorney. Ms. Maher was the FTC’s designated liaison with FDA and the U.S. Department of Agriculture, and worked closely with the staff of both agencies on a wide range of projects and regulatory actions. She directed the development of FTC’s 1994 Food Advertising Enforcement Policy Statement, and was integral in the creation of FTC’s 1998 Dietary Supplement Advertising Guide, and the 1999 Report to Congress on Self-Regulation in the Alcohol Industry. She is a recipient of the Federal Trade Commission’s Award for Distinguished Service. Ms. Maher received her BA from Boston University and her JD from Northeastern University School of Law.

RICHARD CLELAND, ESQ. is an Assistant Director in the division of Advertising Practices at the Federal Trade Commission (FTC). He joined the FTC in 1991. While at the Commission, he has also served as Assistant to the Director of the Bureau of Consumer Protection and Assistant Director of the Division of Advertising Practices. Mr. Cleland’s primary area of expertise is the advertising and marketing of healthcare products and services, and he has served as lead Commission counsel on numerous cases involving weight loss products and other health-related products and services. Prior to joining the FTC, he served as Special Assistant Attorney General and Director of the Division of Consumer Protection in the Iowa Attorney Generals office. Mr. Cleland received his JD from the University of Iowa College of Law.

ROBERT J. MOORE, PhD, is Supervisor of the Dietary Supplement Regulations Implementation Team in the Division of Dietary Supplements Programs, Office of Nutrition, Labeling and Dietary Supplements in the Food and Drug Administration’s (FDA’s) Center for Food Safety and Applied Nutrition (CFSAN). He joined FDA in 1994 and has worked primarily on dietary supplement enforcement and policy development activities. Prior to joining FDA, he served in the U.S. Army as a research biochemist at the US Army Medical Research and Development Command laboratories in Natick, Massachusetts and San Antonio, Texas. Dr. Moore received his undergraduate degrees in Animal Nutrition from the State University of New York at Cobleskill and from the University of Missouri. He received his PhD in Animal Science and Nutrition from the Virginia Polytechnic Institute and State University and completed his post-doctoral research at the U.S. Department of Agriculture (USDA) Human Nutrition Research Center in Grand Forks, ND.

BRUCE A. SILVERGLADE is Director of Legal Affairs at the Center for Science in the Public Interest (CSPI), a nonprofit consumer advocacy organization supported by approximately one million members. Mr. Silverglade coordinates CSPI's legislative and regulatory activities on food labeling and advertising, dietary supplements, nutrition policy, and international issues. He has also supervised federal court litigation and served as counsel in federal court cases involving product labeling and advertising. In 1988 he organized a broad-based coalition effort by health, medical and consumer organizations that culminated in the enactment of the Nutrition Labeling and Education Act of 1990 (NLEA). Prior to joining CSPI, Mr. Silverglade worked at the Federal Trade Commission as a Staff Attorney and later served as an Attorney-Advisor to the Director of the Bureau of Consumer Protection’s Office of Policy and Planning. Mr. Silverglade received his BA, cum laude, in political science from the University of Illinois, where he was a member of Phi Beta Kappa, and his JD from Boston College. He also studied at Harvard Law School as a Special Student in Law and Public Policy.

Minimum requirements to run Conference America’s WebEcho, the service that delivers visual presentations over the web in combination with a standard conference:
Windows 98 / ME / NT / 2000 / XP

Other compatible Operating Systems:
• SPARC Solaris
• Netscape 4.7
• IRIX and HP-UX
• Netscape 4.7
• Red Hat Linux 7.3
• Netscape 4.7
• Mac OSX
• Internet Explorer 5.1
• Netscape 6.2.3

Intel x86 (Pentium 400MHZ +) or compatible processor
256 MB RAM
JavaScript and cookies enabled in the browser
Java 1.4 Plug-in (www.java.com)
56K or faster Internet connection (DSL+ Recommended)